Hyderabad: Hyderabad-based Gland Pharma reported a 38 per cent increase in its net profit for the second quarter of FY22 ended September 30, 2021. The company also said it is on track to make four complex injectable filings in this financial year. Commenting on the results, Srinivas Sadu, MD & CEO of Gland Pharma said, […]
